Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Avior Wealth Management LLC

Avior Wealth Management LLC lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 63.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,082 shares of the biotechnology company’s stock after selling 1,913 shares during the quarter. Avior Wealth Management LLC’s holdings in Axon Enterprise were worth $643,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of AXON. Dimensional Fund Advisors LP raised its holdings in shares of Axon Enterprise by 10.6% during the second quarter. Dimensional Fund Advisors LP now owns 186,473 shares of the biotechnology company’s stock worth $54,874,000 after purchasing an additional 17,905 shares during the last quarter. AE Wealth Management LLC lifted its holdings in Axon Enterprise by 24.8% in the second quarter. AE Wealth Management LLC now owns 831 shares of the biotechnology company’s stock valued at $245,000 after acquiring an additional 165 shares during the period. Public Sector Pension Investment Board boosted its position in Axon Enterprise by 79.5% in the 2nd quarter. Public Sector Pension Investment Board now owns 2,604 shares of the biotechnology company’s stock worth $766,000 after purchasing an additional 1,153 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its stake in shares of Axon Enterprise by 61.5% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 13,730 shares of the biotechnology company’s stock worth $4,040,000 after purchasing an additional 5,230 shares during the period. Finally, MBB Public Markets I LLC purchased a new position in shares of Axon Enterprise during the 2nd quarter valued at approximately $1,412,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the sale, the president now owns 208,166 shares in the company, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the transaction, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of recent analyst reports. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Northland Securities upped their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Finally, JMP Securities upped their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $504.92.

Axon Enterprise Stock Down 0.5 %

AXON stock opened at $610.32 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average of $617.65 and a two-hundred day moving average of $470.75. Axon Enterprise, Inc. has a 12 month low of $247.04 and a 12 month high of $698.67. The company has a market cap of $46.54 billion, a price-to-earnings ratio of 157.71, a PEG ratio of 6.09 and a beta of 1.04.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.